The University of Chicago Header Logo

Connection

Adil Javed to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Adil Javed has written about Treatment Outcome.
Adil Javed
Connection Strength
0.119
Treatment Outcome
  1. Reduction in ocrelizumab-induced infusion reactions by a modified premedication protocol. Mult Scler Relat Disord. 2019 Jan; 27:397-399.
    View in: PubMed
    Score: 0.058
  2. Efficacy and safety of rituximab in pediatric neuromyelitis optica. J Child Neurol. 2011 Feb; 26(2):244-7.
    View in: PubMed
    Score: 0.033
  3. A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab. Mult Scler. 2019 05; 25(6):811-818.
    View in: PubMed
    Score: 0.014
  4. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. Epilepsy Behav. 2018 03; 80:331-336.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.